Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Govt gets Rs 672 crore...

    Govt gets Rs 672 crore fine from pharma cos for overcharging

    Written by savita thakur thakur Published On 2017-03-15T11:09:08+05:30  |  Updated On 15 March 2017 11:09 AM IST
    Govt gets Rs 672 crore fine from pharma cos for overcharging

    New Delhi: Drug pricing regulator NPPA has received Rs 672.28 crore fine till date from pharmaceutical companies for overcharging, Parliament was informed.


    Since inception, the National Pharmaceutical Pricing Authority (NPPA) has issued 1,527 demand notices to companies for overcharging on sales of formulations at prices above the notified ceiling price.


    "Demand notices have been issued for an amount of Rs 5,038.72 crore. Amount of the tune of Rs 672.28 crore has been deposited by the companies. An amount of Rs 3,469.91 crore is under litigation," Minister of State for Chemicals Mansukh L Mandaviya said in a written reply to the Lok Sabha.


    NPPA has recovered Rs 294.84 crore during the current financial year till February, he added.


    The government had recovered Rs 90.17 crore in 2014-15 and Rs 12.36 crore in 2015-16.

    fineNational Pharmaceutical Pricing AuthorityNPPAoverchargingpharmaceutical companiesRs 672.28 crore
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok